糖尿病在中国医疗护理与支付:巨大威胁与巨大机遇

基于2009-2010年中国12地调查,对比糖尿病与正常人群的医疗费用与利用差异。

Figshare
2016-01-19 更新
浏览 12
表格糖尿病医疗费用
Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity

基本信息

模态
表格
大小
0.000665088 GB
许可
CC BY 4.0
创建/更新时间
2016-01-19
版本
v1

资源简介

糖尿病在中国医疗护理与支付:巨大威胁与巨大机遇

【数据集背景】

本数据集源站标题为《Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity》。配套论文《Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity》发表于 PLoS ONE(2012),DOI:10.1371/journal.pone.0039513。源站首次发布:2012-09-26。

【数据内容】

源站原始描述:Background The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care. Methods In 2009–10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%. Findings After adjusting…

【数据结构与技术规格】

文件数 3 个,合计 665.09 KB。File_S1.doc:application/msword,437.25 KB。File_S2.doc:application/msword,196.61 KB。File_S3.doc:application/msword,31.23 KB。数据集 DOI:10.1371/journal.pone.0039513。

【主题与分类】

源站学科分类:Chemistry、Medicine、Biotechnology、Pharmacology。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Medical_Care_and_Payment_for_Diabetes_in_China_Enormous_Threat_and_Great_Opportunity/119462

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Yang, Wenying; Zhao, Wenhui; Xiao, Jianzhong; Li, Rui; Zhang, Ping; Kissimova-Skarbek, Katarzyna; et al. (2016). Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-05-30,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

免费样本无法满足模型训练要求?千方提供经三甲医院脱敏、带病理回证与专家标注的商业级专病数据集。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "File_S1.doc" "https://ndownloader.figshare.com/files/301536"
curl -L -o "File_S2.doc" "https://ndownloader.figshare.com/files/301681"
curl -L -o "File_S3.doc" "https://ndownloader.figshare.com/files/301804"

文件清单

  • File_S1.doc(437.25 KB)
  • File_S2.doc(196.61 KB)
  • File_S3.doc(31.23 KB)

文件总体积 665.09 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care.
Methods
In 2009–10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%.
Findings
After adjusting for age, sex, and urban/rural location, people with diabetes received 1.93 times more days of inpatient treatment, 2.40 times more outpatient visits, and 3.35 times more medications than people with normal glucose tolerance (all pConclusions
In China, health care use and costs were dramatically higher for people with diabetes than for people with normal glucose tolerance and, in relative terms, much higher than in industrialized countries. Low-cost generic medicines that would reduce diabetes expenditures were not fully used.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0039513(source: https://plos.figshare.com/articles/dataset/Medical_Care_and_Payment_for_Diabetes_in_China_Enormous_Threat_and_Great_Opportunity/119462)。

需要用于商业化训练或医疗器械注册(NMPA/FDA)?

公开数据往往缺乏完整的病理回证与专家标注。千方医数集依托陕川双基地与超十家三甲医院直连,提供完全合规、去标识化、支持注册级质控的专病数据集交易服务。